Leung Kam
National Center for Biotechnology Information, NLM, NIH, Bethesda, MD
X-Ray imaging (computed tomography, CT) visualizes tissue density differences that provide the image contrast produced by X-ray attenuation between electron-dense bone and soft tissues (1). Contrast enhancement with use of X-ray contrast (radiopaque) agents are needed to increase the degree of contrast between diseased tissues from normal tissues. Water-soluble X-ray contrast agents are generally based on small tri-iodobenzene compounds as monomers or dimmers (2), which can be ionic (high osmolality) or nonionic (low osmolality). When injected intravenously (intra-arterial catheterization is commonly used), they exhibit highly non-specific vascular permeation and rapid renal excretion limiting their targeting performance. Gold has not been used as an X-ray contrast agent . Gold has a higher atomic number and a higher absorption coefficient than iodine, providing 2.7-fold greater contrast/weight than iodine (3). Furthermore, imaging gold at 80-100 keV reduces interference from bone absorption and provides lower soft tissue absorption, which would reduce radiation to patient. Hainfeld et al. (3) have performed experiments in mice using gold nanoparticles (AuNPs, 1.9 nm in diameter, ~50 kDa) as a CT contrast agent. This preparation exhibit excellent stability, high X-ray absorption, good safety profile, long blood half-life, and enhanced CT contrast of the vasculature, kidneys and tumor in mice.
X射线成像(计算机断层扫描,CT)可显示组织密度差异,这些差异提供了由电子致密骨和软组织之间的X射线衰减产生的图像对比度(1)。需要使用X射线造影剂(不透射线)进行对比增强,以增加病变组织与正常组织之间的对比度。水溶性X射线造影剂通常基于小三碘苯化合物作为单体或二聚体(2),它们可以是离子型(高渗透压)或非离子型(低渗透压)。当静脉注射时(通常使用动脉内导管插入术),它们表现出高度非特异性的血管渗透和快速的肾脏排泄,限制了它们的靶向性能。金尚未用作X射线造影剂。金的原子序数和吸收系数比碘高,提供的对比度/重量比碘大2.7倍(3)。此外,在80-100 keV下对金进行成像可减少骨吸收的干扰,并降低软组织吸收,这将减少对患者的辐射。海因费尔德等人(3)在小鼠中使用金纳米颗粒(AuNP,直径1.9 nm,约50 kDa)作为CT造影剂进行了实验。这种制剂表现出优异的稳定性、高X射线吸收、良好的安全性、长血液半衰期以及增强的小鼠血管、肾脏和肿瘤的CT对比度。